BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20823007)

  • 1. Clinical implications of MRI to assess cardiac and pulmonary function in patients with duchenne muscular dystrophy.
    Finsterer J; Stöllberger C
    Chest; 2010 Sep; 138(3):756-7; author reply 757. PubMed ID: 20823007
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac assessment of patients with Becker's muscular dystrophy.
    Ionescu CN; Kapoor A; Protopapas Z; Marcu CB
    Conn Med; 2009 Aug; 73(7):395-7. PubMed ID: 19708317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement.
    Finder JD; Birnkrant D; Carl J; Farber HJ; Gozal D; Iannaccone ST; Kovesi T; Kravitz RM; Panitch H; Schramm C; Schroth M; Sharma G; Sievers L; Silvestri JM; Sterni L;
    Am J Respir Crit Care Med; 2004 Aug; 170(4):456-65. PubMed ID: 15302625
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and patterns of cardiac involvement in duchenne muscular dystrophy.
    Ahuja R; Kalra V; Saxena A; Dua T
    Indian Pediatr; 2000 Nov; 37(11):1246-51. PubMed ID: 11086308
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
    Tandon A; Villa CR; Hor KN; Jefferies JL; Gao Z; Towbin JA; Wong BL; Mazur W; Fleck RJ; Sticka JJ; Benson DW; Taylor MD
    J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal dysfunction can occur in advanced-stage Duchenne muscular dystrophy.
    Motoki T; Shimizu-Motohashi Y; Saito I; Komaki H; Ishiyama A; Aibara K; Jogamoto T; Tezuka Y; Kawabe M; Makino A; Nagatani K; Tatara K; Kuwabara K; Kikuchi C; Fukuda M; Ishii E; Eguchi M
    Muscle Nerve; 2020 Feb; 61(2):192-197. PubMed ID: 31725904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin T and troponin I in carriers of Duchenne and Becker muscular dystrophy with cardiac involvement.
    Hoogerwaard EM; Schouten Y; van der Kooi AJ; Gorgels JP; de Visser M; Sanders GT
    Clin Chem; 2001 May; 47(5):962-3. PubMed ID: 11325912
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.
    Daftary AS; Crisanti M; Kalra M; Wong B; Amin R
    Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne Muscular Dystrophy longitudinal pulmonary assessment and management.
    Mayer OH
    Paediatr Respir Rev; 2019 Apr; 30():1. PubMed ID: 30553654
    [No Abstract]   [Full Text] [Related]  

  • 11. Perioperative complications of scoliosis surgery in patients with Duchenne muscular dystrophy and spinal muscular atrophy, focussing on wound healing disorders.
    Burow M; Forst R; Forst J; Hofner B; Fujak A
    Int J Neurosci; 2017 Jun; 127(6):479-485. PubMed ID: 27251216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence or absence of cardiac disease in Duchenne muscular dystrophy.
    Finsterer J
    Cardiology; 2012; 121(3):184-5. PubMed ID: 22508155
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial strain imaging for early detection of cardiac involvement in patients with Duchenne's progressive muscular dystrophy.
    Mori K; Hayabuchi Y; Inoue M; Suzuki M; Sakata M; Nakagawa R; Kagami S; Tatara K; Hirayama Y; Abe Y
    Echocardiography; 2007 Jul; 24(6):598-608. PubMed ID: 17584199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: an MRI study.
    Mavrogeni S; Tzelepis GE; Athanasopoulos G; Maounis T; Douskou M; Papavasiliou A; Cokkinos DV
    Chest; 2005 Jan; 127(1):143-8. PubMed ID: 15653975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracardiac thrombus and cerebral infarction in a patient with duchenne muscular dystrophy.
    Gimenez-Muñoz A; Capablo JL; Alarcia R; Torné L; Errea JM
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):79-80. PubMed ID: 19955989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Not Available].
    Beckmann E; Vignaux JJ
    Med Sci (Paris); 2016 Nov; 32 Hors série n°2():22-26. PubMed ID: 27869073
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-compaction on autopsy in Duchenne muscular dystrophy.
    Finsterer J; Stöllberger C; Feichtinger H
    Cardiology; 2007; 108(3):161-3. PubMed ID: 17077629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
    Mavrogeni S; Giannakopoulou A; Papavasiliou A; Markousis-Mavrogenis G; Pons R; Karanasios E; Noutsias M; Kolovou G; Papadopoulos G
    BMC Cardiovasc Disord; 2017 Jul; 17(1):197. PubMed ID: 28738778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac phenotype determines survival in Duchenne muscular dystrophy.
    Birnkrant DJ; Ararat E; Mhanna MJ
    Pediatr Pulmonol; 2016 Jan; 51(1):70-6. PubMed ID: 26097149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
    Fayssoil A
    Indian Heart J; 2010; 62(3):273. PubMed ID: 21275309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.